Human herpesvirus 8 (HHV-8) infection in healthy urban employees from Greece: Seroprevalence and associated factors

Journal of Medical Virology

Volumn 79, Issue 5, 2007, Pages 591-596

  Zavitsanou, Assimina ^a   Sypsa, Vana ^a   Petrodaskalaki, Maria ^a   Kalapothaki, Victoria ^a   Whitby, Denise ^b   Hatzakis, Angelos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b SAIC FREDERICK INC   (United States)

Author keywords

HHV 8; Risk factors; Seroepidemiology

Indexed keywords

ADULT; ARTICLE; BLOOD TRANSFUSION; EMPLOYEE; ENZYME LINKED IMMUNOSORBENT ASSAY; FATIGUE; FEMALE; GREECE; HEPATITIS C VIRUS; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SEROEPIDEMIOLOGY; SEROPREVALENCE; SEXUAL BEHAVIOR; TATTOO; URBAN AREA; WEAKNESS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIBODIES, VIRAL; CARRIER STATE; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GREECE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL HEALTH; PREVALENCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; URBAN POPULATION;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN HERPESVIRUS 8;

EID: 34147121132     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20812     Document Type: Article

References (42)

1. Andreoni M, El-Sawaf G, Rezza G, Ensoli B, Nicastri E, Ventura L, Ercoli L, Sarmati L, Rocchi G. 1999. High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: Evidence of non-sexual transmission. J Natl Cancer Inst 91:465-469.
2. Antman K, Chang Y. 2000. Kaposi's sarcoma. N Engl J Med 342:1027-1038.
3. Belec L, Cancre N, Hallouin MC, Morvan J, Si Mohamed A, Gresenquet G. 1998. High prevalence in Central Africa of blood donors who are potentially infectious for human herpesvirus 8. Transfusion 38:771-775.
4. Biggar RJ, Whitby D, Marshall V, Linhares AC, Black F. 2000. Human herpesvirus 8 in Brazilian Amerindians: A hyperendemic population with a new subtype. J Infect Dis 181:1562-1568.
5. Calabro ML, Sheldon J, Favero A, Simpson GR, Fiore JR, Gomes E, Angarano G, Chieco-Bianchi L, Schulz TF. 1998. Seroprevalence and Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy. J Hum Virol 1:207-213.
6. Cannon MJ, Bollard SC, Smith DK, Klein RS, Schuman P, Rich JD, Vlahov D, Pellett PE. HIV Epidemiology Research Study Group. 2001. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med 344:637-643.
7. Cattani P, Cerimele F, Porta D, Graffeo R, Ranno S, Marchetti S, Ricci R, Capodicasa N, Fuga L, Amico R, Cherchi G, Gazzilli M, Zanetti S, Fadda G. 2003. Age-specific seroprevalence of Human Herpes-virus8 in Mediterranean regions. Clin Microbiol Infect 9:274-279.
8. Chatlynne LG, Lapps W, Handy M, Huang YQ, Masood R, Hamilton AS, Said JW, Koeffler HP, Kaplan MH, Friedman-Kien A, Gill PS, Whitman JE, Ablashi DV. 1998. Detection and titration of human-herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood 92:53-58.
9. Crispo A, Tamburini M, De Marco MR, Ascierto P, Silvestro P, Ronga D, Tridente V, Desicato S, Carbone S, Fabbrocini G, Spiteri D, Montella M. 2001. HHV-8 prevalence, immunosuppression and Kaposi's sarcoma in South Italy. Int J Mol Med 7:535-538.
10. Davidovici B, Karakis I, Bourboulia D, Ariad S, Zong J, Benharroch D, Dupin N, Weiss R, Hayward G, Sarov B, Boshoff C. 2001. Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel. J Natl Cancer Inst 93:194-202.
11. Engels EA, Whitby D, Goebel PB, Stossel A, Waters D, Pintus A, Contu L, Biggar RJ, Goedert JJ. 2000a. Identifying human herpesvirus 8 infection: Performance, characteristics of serologic assays. J Acquir Immune Defic Syndr 23:346-354.
12. Engels EA, Sinclair MD, Biggar RJ, Whitby D, Ebbesen P, Goedert JJ, Gastwirth JL. 2000b. Latent class analysis of human herpesvirus 8 assay performance and infection prevalence in sub-saharan Africa and Malta. Int J Cancer 88:1003-1008.
13. Fujii T, Taguchi H, Katano H, Mori S, Nakamura T, Nojiri N, Nakajima K, Tadokoro K, Juji T, Iwamoto A. 1999. Seroprevalence of human herpesvirus 8 in human immunodeficiency virus 1-positive and human immunodeficiency virus 1-negative populations in Japan. J Med Virol 57:159-162.
14. Gambus G, Bourboulia D, Esteve A, Lahoz R, Rodriguez C, Bolao F, Sirera G, Muga R, del Romero J, Boshoff C, Whitby D, Casabona J. 2001. Prevalence and distribution of HHV-8 in different subpopulations with and without HIV infection, in Spain. AIDS 15:1167-1174.
15. Hladik W, Dollard SC, Downing RG, Kataaha P, Pellett PE, Karon JM, Mermin J, Lackritz EM. 2003. Kaposi's sarcoma in Uganda: Risk factors for human herpesvirus 8 infection among blood donors. J Acquir Immune Defic Syndr 33:206-210.
16. Huang YQ, Li JJ, Kaplan MH, Poiesz B, Katabira E, Zhang WC, Feiner D, Friedman-Kien AE. 1995. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 345:759-761.
17. Iscovich J, Fischbein A, Fisher-Fischbein J, Freedman LS, Eng SM, Boffetta P, Vudovich A, Glasman C, Goldschmidt R, Livingston M, Heger-Maslansky B, Brennan P, Moore PS. 2000. Seroprevalence of Kaposi's sarcoma-associated herpesvirus in healthy adults in Israel. Anticancer Res 20:2119-2122.
18. Kaloterakis A, Stratigos S, Trichopoulos D, Karabinis A, Elemenoglou S. 1984. Mediterranean Kaposi's sarcoma: Preliminary communication about 131 cases. Bull Soc Pathol Exot Filiales 77:570-571.
19. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. 1996. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus}: Distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 2:918-924.
20. Larocca L, Leto D, Celesta BM, Maccarone S, Mazza C, Cacopardo B, Nigro L. 2005. Prevalence of antibodies to HHV-8 in the general population and in individuals at risk for sexually transmitted and blood-borne infections in Catania, Eastern Sicily. Infez Med 13:79-85.
21. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. 1998. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 338:948-954.
22. Mayama S, Cuevas LE, Sheldon J, Omar OH, Smith DH, Okong P, Silvel B, Hart CA, Schulz TF. 1998. Prevalence and transmission of Kaposi's sarcoma associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 77:817-820.
23. Melbye M, Cook PM, Hjalgrim H, Begtrup K, Simpson GR, Biggar RJ, Ebbesen P, Schulz TF. 1998. Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996. Int J Cancer 77:543-548.
24. Nelson DB. 2003. Infection control during gastrointestinal endoscopy. J Lab Clin Med 141:159-167.
25. Pauk J, Huang ML, Brodie SJ, Wald A, Koelle DM, Schacker T, Celum C, Selke S, Corey L. 2000. Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 343:1369-1377.
26. Perna AM, Bonura F, Vitale F, Viviano E, Di Benedetto MA, Ajello F, Villafrate MR, Prestileo T, Mancuso S, Goedert JJ, Romano N. 2000. Antibodies to human herpes virus type 8 (HHV-8) in general population and in individuals at risk for sexually transmitted diseases in Western Sicily. Int J Epidemiol 29:175-179.
27. Rabkin CS, Schulz TF, Whitby D, Lennette ET, Magpantay LI, Chatlynne L, Biggar RJ. 1998. Inter-assay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group. J Infect Dis 178:304-309.
28. Schinaia N, Kodra Y, Sarmati L, Andreoni M, Bino S, Qyra S, Rezza G. 2004. Prevalence of HHV-8 infection in Albanian adults and association with HBV and HCV. Eur J Epidemiol 19:467-469.
29. Schulz TF. 1998. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). J Gen Virol 79:1573-1591.
30. Serraino D, Toma L, Andreoni M, Butto S, Tchangmena O, Sarmati L, Monini P, Franceschi S, Ensoli B, Rezza G. 2001. A seroprevalence study of human herpesvirus type 8 (HHV-8) in eastern and Central Africa and in the Mediterranean area. Eur J Epidemiol 17:871-876.
31. Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao SJ, Bohenzky RA, Simmonds P, Lee C, de Ruiter A, Hatzakis A, Tedder RS, Weller IV, Weiss RA, Moore PS. 1996. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 348:1133-1138.
32. Sitas F, Newton R. 2001. Kaposi's sarcoma in South Africa. J Natl Cancer Inst Monogr 28:1-4.
33. Sitas F, Carrara H, Beral V, Newton R, Reeves G, Bull D, Jentsch U, Pacella-Norman R, Bourboulia D, Whitby D, Boshoff C, Weiss R. 1999. Antibodies against human herpesvirus 8 in South African patients with cancer. N Engl J Med 340:1863-1871.
34. Stein L, Carrara H, Norman R, Alagiozoglou L, Morris L, Sitas F. 2004. Antibodies against human herpesvirus 8 in South African renal transplant recipients and blood donors. Transplant Infect Dis 6:69-73.
35. Stratigos JD, Katoulis AC, Stavrianeas NG. 1999. An overview of classic Kaposi's sarcoma in Greece. Adv Exp Med Biol 455:503-506.
36. Sypsa V, Hadjipaschali E, Hatzakis A. 2001. Prevalence, risk factors and evaluation of a screening strategy for chronic hepatitis C and B virus infections in healthy company employees. Eur J Epidemiol 17:721-728.
37. Touloumi G, Kaklamanis L, Potouridou I, Katsika-Hatziolou E, Stratigos J, Mueller N, Hatzakis A. 1997. The epidemiologic profile of Kaposi's sarcoma in Greece prior to and during the AIDS era. Int J Cancer 70:538-541.
38. Vitale F, Viviane E, Perna AM, Bonura F, Mazzola G, Ajello F, Romano N. 2000. Serological and virological evidence of non-sexual transmission of human herpesvirus type 8 (HHV-8). Epidemiol Infect 125:671-675.
39. Weiss RA, Whitby D, Talbot S, Kellam P, Boshoff C. 1998. Human herpesvirus type 8 and Kaposi's sarcoma. J Natl Cancer Inst Monogr 23:51-54.
40. Whitby D, Boshoff C. 1998. Kaposi's sarcoma herpesvirus as a new paradigm for virus induced oncogenesis. Curr Opin Oncol 10:405-412.
41. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hatzioannou T, Suggett FE, Aldam DM, Denton AS. 1995. Detection of Kaposi's sarcoma associated herpesvirus (KSHV) in peripheral blood of HIV-infected individuals prior to progression to Kaposi's sarcoma. Lancet 346:799-802.
42. Zhu L, Wang R, Sweat A, Goldstein E, Horvat R, Chandran B. 1999. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV-8) proteins associated with the latent (ORF73) and lytic (ORFs 65,1A, andK8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-I cells. Virology 256:381-392.